Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1977 Dec;36(6):700–707. doi: 10.1038/bjc.1977.252

Biochemical markers in bronchial carcinoma.

C G McKenzie, I M Evans, C J Hillyard, P Hill, S Carter, M K Tan, I MacIntyre
PMCID: PMC2025577  PMID: 202297

Abstract

A total of 107 patients with bronchial carcinoma have been studied for the presence of potential circulating tumour markers which might be used as indicators of recurrence after primary treatment. Plasma carcinoembryonic antigen (CEA) levels were estimated in every patient and, after a preliminary hormone screening study, plasma calcitonin (CT) and parathyroid hormone (PTH) levels were assayed in 66 patients. Oat-cell tumours proved to be of particular interest in that CEA levels greater than 40 microgram/l were measured (initially or subsequently) in 40.6 percent and CT levels were elevated in 75 percent. Longitudinal studies point towards the possible use of elevated marker levels as guides to therapy when all other features of recurrent disease are lacking. It is clear that no ideal tumour marker exists for bronchial carcinoma but in an individual case an abnormal level of one or more marker substances may provide a valuable aid to treatment.

Full text

PDF
703

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Choi C. H., Carey R. W. Small cell anaplastic carcinoma of lung. Reappraisal of current management. Cancer. 1976 Jun;37(6):2651–2657. doi: 10.1002/1097-0142(197606)37:6<2651::aid-cncr2820370612>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  2. Cochran J. S., Walsh P. C., Porter J. C., Nicholson T. P., Peters P. C. Clinical evaluation of human chorionic gonadotropin levels in men with testicular tumors. Surg Forum. 1974;25(0):542–543. [PubMed] [Google Scholar]
  3. Coombes R. C., Hillyard C., Greenberg P. B., MacIntyre I. Plasma-immunoreactive-calcitonin in patients with non-thyroid tumours. Lancet. 1974 Jun 1;1(7866):1080–1083. doi: 10.1016/s0140-6736(74)90557-1. [DOI] [PubMed] [Google Scholar]
  4. Crawford J. W. Follow-up of hydatidiform mole by radioimmunoassay of human chorionic gonadotrophin. Br Med J. 1972 Dec 23;4(5842):715–719. doi: 10.1136/bmj.4.5842.715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Eagan R. T., Maurer L. H., Forcier R. J., Tulloh M. Proceedings: Small cell carcinoma of the lung: staging, paraneoplastic syndromes, treatment, and survival. Cancer. 1974 Feb;33(2):527–532. doi: 10.1002/1097-0142(197402)33:2<527::aid-cncr2820330230>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  6. Greenberg P. B., Doyle F. H., Fisher M. T., Hillyard C. J., Joplin G. F., Pennock J., MacIntyre I. Treatment of Paget's disease of bone with synthetic human calcitonin: biochemical and roentgenologic changes. Am J Med. 1974 Jun;56(6):867–870. doi: 10.1016/0002-9343(74)90816-x. [DOI] [PubMed] [Google Scholar]
  7. HORWITZ H., WRIGHT T. L., PERRY H., BARRETT C. M. "SUPPRESSIVE" CHEMOTHERAPY IN BRONCHOGENIC CARCINOMA: A RANDOMIZED PROSPECTIVE CLINICAL TRIAL. Am J Roentgenol Radium Ther Nucl Med. 1965 Mar;93:615–638. [PubMed] [Google Scholar]
  8. Hansen H. J., Snyder J. J., Miller E., Vandevoorde J. P., Miller O. N., Hines L. R., Burns J. J. Carcinoembryonic antigen (CEA) assay. A laboratory adjunct in the diagnosis and management of cancer. Hum Pathol. 1974 Mar;5(2):139–147. doi: 10.1016/s0046-8177(74)80061-4. [DOI] [PubMed] [Google Scholar]
  9. Hillyard C. J., Cooke T. J., Coombes R. C., Evans I. M., Macintyre I. Normal plasma calcitonin: circadian variation and response to stimuli. Clin Endocrinol (Oxf) 1977 Apr;6(4):291–298. doi: 10.1111/j.1365-2265.1977.tb02014.x. [DOI] [PubMed] [Google Scholar]
  10. Hornback N. B., Einhorn L., Shidnia H., Joe B. T., Krause M., Furnas B. Oat cell carcinoma of the lung. Early treatment results of combination radiation therapy and chemotherapy. Cancer. 1976 Jun;37(6):2658–2664. doi: 10.1002/1097-0142(197606)37:6<2658::aid-cncr2820370613>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  11. Johnson R. E., Brereton H. D., Kent C. H. Small-cell carcinoma of the lung: attempt to remedy causes of past therapeutic failure. Lancet. 1976 Aug 7;2(7980):289–291. doi: 10.1016/s0140-6736(76)90736-4. [DOI] [PubMed] [Google Scholar]
  12. Keogh B., Hreshchyshyn M. M., Moore R. H., Merrin C. E., Murphy G. P. Urinary gonadotropins in management and prognosis of testicular tumor. Urology. 1975 Apr;5(4):496–503. doi: 10.1016/0090-4295(75)90074-6. [DOI] [PubMed] [Google Scholar]
  13. Laurence D. J., Stevens U., Bettelheim R., Darcy D., Leese C., Turberville C., Alexander P., Johns E. W., Neville A. M. Role of plasma carcinoembryonic antigen in diagnosis of gastrointestinal, mammary, and bronchial carcinoma. Br Med J. 1972 Sep 9;3(5827):605–609. doi: 10.1136/bmj.3.5827.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mackay A. M., Patel S., Carter S., Stevens U., Laurence D. J., Cooper E. H., Neville A. M. Role of serial plasma C.E.A. assays in detection of recurrent and metastatic colorectal carcinomas. Br Med J. 1974 Nov 16;4(5941):382–385. doi: 10.1136/bmj.4.5941.382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Vincent R. G., Chu T. M. Carcinoembryonic antigen in patients with carcinoma of the lung. J Thorac Cardiovasc Surg. 1973 Aug;66(2):320–328. [PubMed] [Google Scholar]
  16. Vincent R. G., Chu T. M., Fergen T. B., Ostrander M. Carcinoembryonic antigen in 228 patients with carcinoma of the lung. Cancer. 1975 Dec;36(6):2069–2076. doi: 10.1002/cncr.2820360923. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES